Начало・Списък с акции・Champions Oncology Inc

C
Champions Oncology Inc

Отворен

СекторЗдравеопазване

5.37 0.19

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

5.26

Максимум

5.55

Ключови измерители
By Trading Economics
Приходи	-389K -667K
Продажби	1.5M 17M
P/E Средно за сектора	35.118 64.641
EPS	-0.05
Марж на печалбата	-4.028
Служители	213
EBITDA	-626K -522K

Дивиденти
By Acuity
Следващи печалби	11.09.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-555K 84M
Предишно отваряне	5.18
Предишно затваряне	5.37

Настроения в новините

By Acuity

15%

85%

25 / 340 Класиране в Healthcare

Champions Oncology Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.08.2026 г., 20:13 ч. UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

31.07.2026 г., 19:46 ч. UTC

Champions Oncology Inc shares are higher today, reflecting a positive move since Thursday's close, though still below the 20-day moving average.

30.07.2026 г., 17:16 ч. UTC

Champions Oncology is trading lower today, continuing a trend of declines over the past three sessions, despite positive broader market sentiment.

29.07.2026 г., 19:02 ч. UTC

Champions Oncology Inc is trading higher during Wednesday's session, breaking from its recent upward trend. Broader market dynamics are influenced by rising oil prices.

28.07.2026 г., 19:32 ч. UTC

Champions Oncology Inc. shares are trading lower amid broader market declines, particularly in technology sectors across Asia, with no specific company news identified.

27.07.2026 г., 23:01 ч. UTC

News

Champions Oncology shares declined in after-market trading following mixed fourth-quarter earnings, despite adjusted EPS of $0.01 and record annual revenue of $59.4 million.

24.07.2026 г., 20:06 ч. UTC

Champions Oncology Inc shares are advancing, despite earlier intraday volatility. Broader market sentiment reflects easing inflation concerns amid significant oil price drops.

22.07.2026 г., 19:41 ч. UTC

Champions Oncology shares are declining during Wednesday's session, with no specific news identified. Broader market concerns are driven by rising crude oil prices.

Сравнение с други в отрасъла

Ценова промяна

Champions Oncology Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Champions Oncology Inc през последните 3 месеца.

Настроение

By Acuity

25 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.